Navigation Links
Halozyme Therapeutics and ViroPharma Announce $83 Million Global Licensing Agreement to Develop Subcutaneous Cinryze® (C1 esterase inhibitor [human])
Date:5/11/2011

SAN DIEGO, May 11, 2011 /PRNewswire/ -- Halozyme Therapeutics, Inc. (Nasdaq: HALO) and ViroPharma Incorporated (Nasdaq: VPHM), today announced the signing of a worldwide exclusive licensing agreement for the use of rHuPH20 (recombinant human hyaluronidase) in the development of a subcutaneous formulation of Cinryze (C1 esterase inhibitor [human]). Under terms of the agreement, Halozyme may receive up to $83 million, commencing with an upfront payment of $9 million and total potential future milestone payments of $74 million dependent upon the achievement of clinical and regulatory targets, plus a 10% royalty on future sales of the combination of Cinryze with rHuPH20. The license provides ViroPharma with exclusivity to C1 esterase inhibition and to the hereditary angioedema (HAE) indication, along with three additional orphan indications. ViroPharma will fund all development and commercialization expenses for the program. Additional terms of the transaction have not been disclosed.

(Logo:  http://photos.prnewswire.com/prnh/20100302/LA63139LOGO)

Cinryze has received FDA approval for intravenous administration for routine prophylaxis against angioedema attacks in adolescent and adult patients with hereditary angioedema. A combination formulation of Cinryze with rHuPH20 for subcutaneous, or under the skin, administration is expected to enter clinical trials by the end of the year. The initial focus of the collaboration will be on the development of a novel subcutaneous formulation of Cinryze for routine prophylaxis against attacks of HAE.

"Halozyme's rHuPH20 enzyme may facilitate the subcutaneous administration and absorption of a broad range of pharmaceuticals and biologics, including plasma-derived proteins suc
'/>"/>

SOURCE Halozyme Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor
2. Halozyme Therapeutics to Present at the Bank of America Merrill Lynch Health Care Conference on May 12
3. Halozyme Therapeutics to Host First Quarter 2011 Financial Results Conference Call on May 6
4. Halozyme Therapeutics Reports Fourth Quarter and Year End 2010 Financial Results
5. Halozyme Therapeutics to Host Fourth Quarter and 2010 Financial Results Conference Call on March 11
6. Halozyme Therapeutics to Present at J.P. Morgan Healthcare Conference on January 12
7. Halozyme Therapeutics Realigns Management
8. Halozymes rHuPH20 With Recombinant Human Insulin Demonstrates Glycemic Control Comparable to Lispro
9. Halozyme Therapeutics Announces Implementation of Development Focused Strategy
10. Halozyme Therapeutics to Host Analyst Meeting on October 14 in New York
11. Halozyme Therapeutics Announces Public Offering of Common Stock
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... Research and Markets has announced ... Packaging Industry Report 2014" report to their offering. ... The Global and Chinese Aseptic Packaging Industry Report is ... of the global Aseptic Packaging industry with a focus ... basic overview of the industry including definitions, classifications, applications ...
(Date:7/30/2014)... 2014  Decision Resources Group finds that ... research imaging system market will be significantly driven ... combining computed tomography and magnetic resonance imaging with ... from the need for higher-quality imaging to satisfy ... will spur preclinical imaging system sales. ...
(Date:7/30/2014)... 2014   Unique Pizza and Subs Corporation ... UPZS), a Delaware Corporation, is pleased to announce ... Pharmaceutical Corporation ("Larasan"), a nature-based pharmaceutical company that produces ... US-based Larasan will work with Unique to help ... Larasan,s vast distribution network throughout China ...
Breaking Medicine Technology:Global and Chinese Aseptic Packaging Industry Report 2014 2Growing Popularity of Multimodality Imaging Will Drive the Preclinical Animal Research Imaging System Market 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 2Unique Pizza and Subs Announces Asian Distribution Agreement with Larasan Pharmaceutical Corporation 3
... ASSERT Trial Presented at EULAR, BARCELONA, Spain, ... at the European League Against Rheumatism (EULAR),Annual ... with,ankylosing spondylitis (AS) who received REMICADE(R) (infliximab),over ... In addition, REMICADE-treated patients showed sustained,reductions in ...
... Biotech (OMX Nordic: ACTI) presented,pre-clinical results for ... (The,European League Against Rheumatism, <a target="_blank" href=,"http://www.eular.org/">www.eular.org ... pre-clinical data presented show that I-3D has ... an,experimental model for rheumatoid arthritis (RA)", commented ...
Cached Medicine Technology:Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 2Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 3Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 4Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 5Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 6Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 7Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 8Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 9Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 10Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 11Remicade Two Year Data in Ankylosing Spondylitis Show Improvement,in Spinal Mobility and Spinal Inflammation 12New Positive Pre-clinical Data for Active Biotech's RA Project I-3D 2
(Date:7/31/2014)... 31, 2014 In its latest blog post, ... believes that having family close by during a stay in ... the process is successful, is looking at 10 tips to ... , “Addiction recovery is a lifelong process, and one that ... committed to without compromise,” commented Best Drug Rehabilitation’s CEO ...
(Date:7/31/2014)... 2014 The study, The Truth ... Medicare episode of care payments for four clinical areas—congestive ... joint replacements (hips and knees). Using the definition ... for Care Improvement program, the study examines these clinical ... in the country. , “Our study reaffirms that, in ...
(Date:7/30/2014)... The Mesothelioma Applied Research Foundation ... Center, will host a regional conference on ... field of mesothelioma. September 26 marks the National Mesothelioma ... the public, and specifically aimed at mesothelioma patients, family ... exposed to asbestos. , The conference will take place ...
(Date:7/30/2014)... Regardless of traumatic events experienced during deployment, returning ... a drinking problem if faced with civilian life ... serious financial and legal problemsall commonplace in military ... Columbia University,s Mailman School of Public Health are ... Preventive Medicine . , Alcohol abuse is a ...
(Date:7/30/2014)... “United States Orthopedic Braces and Supports Market Outlook to 2020?, ... and Supports market. The report provides value, in millions of ... (in US dollars), within market categories:, ... Supports , Spinal Braces and Supports , ... is a specialty within the medical field concerned with the ...
Breaking Medicine News(10 mins):Health News:New Best Drug Rehabilitation Blog Posts Looks at 10 Tips for Coping After Drug or Alcohol Rehab 2Health News:Recent Research Finds a New Driver of Cost Variation in Episode Payments 2Health News:Recent Research Finds a New Driver of Cost Variation in Episode Payments 3Health News:September Events: Regional Conference on Mesothelioma in Philadelphia 2Health News:September Events: Regional Conference on Mesothelioma in Philadelphia 3Health News:Vets' alcohol problems linked to stress on the home front 2Health News:US Orthopedic Braces and Supports Market (Knee, Ankle & Spinal) to 2020 Report Available at MarketOptimizer.org 2Health News:US Orthopedic Braces and Supports Market (Knee, Ankle & Spinal) to 2020 Report Available at MarketOptimizer.org 3Health News:US Orthopedic Braces and Supports Market (Knee, Ankle & Spinal) to 2020 Report Available at MarketOptimizer.org 4
... Healthcare and personal care items shipped to QualComm Stadium and other ... for distribution to evacuees, Prescription delivery service from CVS to Qualcomm ... ... filled, WOONSOCKET, R.I., Oct. 24 CVS/pharmacy, the retail,division of CVS Caremark ...
... good to eat," they,re hoping for candy -- and ... but also a tradition that causes,concern about the effects ... and common sense, however, parents can help protect their ... of sugar in Halloween candy is stunning," said Dr. ...
... early gained some symptom relief, study found , , WEDNESDAY, ... month,s worth of inhaler medicine may have lessened rescue ... 11, 2001, World Trade Center attacks, according to new ... anti-inflammatory medicines commonly used for the treatment of asthma. ...
... Washington, D.C.More than three quarters of adults living in ... factor for stroke, but those who are poor do ... wealthier counterparts. In an effort to address these disparities ... NIH,s National Institute of Neurological Disorders and Stroke (NINDS) ...
... advice in approaching decisions about life, career, having a ... of the Institute for Operations Research and the Management ... Research Professor of Decision Sciences at the Fuqua School ... A Practical Guide to Making Better Decisions, a Harvard ...
... messages from meaningless noise could be an early sign ... of Medicine researchers. , The study this month in ... diagnosed with prodromal symptoms meaning they exhibited early warning ... alterations, or misinterpretation of social cues. , Participants in ...
Cached Medicine News:Health News:CVS/pharmacy Donates More Than $300,000 in Supplies to Aid Fire Relief Efforts in California 2Health News:Parents: With Halloween Candy, Focus on Choice and Time to Prevent Teeth Decay 2Health News:Inhaler Eased Lung Problems in 9/11 Workers 2Health News:Inhaler Eased Lung Problems in 9/11 Workers 3Health News:Georgetown leads major effort to combat disparities in DC stroke care 2Health News:Georgetown leads major effort to combat disparities in DC stroke care 3Health News:Trouble deciding? 2Health News:Trouble deciding? 3
... System provides anterior column support for single ... T1 to L5. The system consists of ... cages that are stacked to a desired ... Carbon Fiber Reinforced Polymer material emulates the ...
... provides anterior column support for single or ... to L5. The system consists of one ... that are stacked to a desired height, ... Fiber Reinforced Polymer material emulates the biomechanical ...
... Cage system is a carbon fiber reinforced ... and biologic functions of posterior lumbar interbody ... provides a device designed to meet the ... cancellous bone, the best possible bone for ...
... is highly adaptable and therefore suitable for ... to its extraordinary small outer diameter and ... of a simple but secure and reliable ... steering instruments around the corner. These characteristics ...
Medicine Products: